Practical Suggestions for an Optimal Management of Vitamin K Antagonists: Italian Federation of Centers for the Diagnosis of Thrombotic Disorders and the Surveillance of the Antithrombotic Therapies (FCSA) Position Paper
Thrombosis and Haemostasis · 01.08.2024 · 124 (08) · 803-809
DOI: 10.1055/s-0044-1782688 ↗Kurz gefasst
Leitlinie in der Zeitschrift Thrombosis and Haemostasis, erschienen am 01.08.2024. Verfasst von Silvia Galliazzo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Research Center on Thromboembolic Disorders and Antithrombotic Therapies, University of Insubria, Sant'Anna Hospital, ASST Lariana, Como, Italy. Hauptthemen laut MEDLINE: Vitamin K, Warfarin, Anticoagulants, International Normalized Ratio. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
In the era of direct oral anticoagulants, vitamin K antagonists retain a clinically relevant role in thrombotic disorders. In Italy, approximately 20% of the patients on anticoagulant therapies receives a VKA, in most cases warfarin. The optimal management of this drug is challenging and cannot disregard its intricate and unpredictable pharmacokinetic properties and patient's thrombotic and bleeding risk. Several clinical issues encountered during warfarin treatment are still unanswered and are tentatively addressed by physicians. In this regard, the Italian Federation of Centers for the diagnosis of thrombotic disorders and the Surveillance of the Antithrombotic therapies (FCSA) provides some experience-based good clinical practice's suggestions on the following topics: (1) how to start the anticoagulant treatment with warfarin and warfarin induction regimen; (2) how to manage a subtherapeutic INR value; (3) how to manage a supratherapeutic INR value in asymptomatic patients; and (4) how to manage the association of warfarin with interfering drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Research Center on Thromboembolic Disorders and Antithrombotic Therapies, University of Insubria, Sant'Anna Hospital, ASST Lariana, Como, Italy.
- Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy.
- Thrombosis and Haemostasis Unit, University of Cagliari, Cagliari, Italy.
- Haemostasis Center, AORN S.G. Moscati, Avellino, Italy.
- Thrombosis and Haemostasis Unit, IRCCS, Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
- Haemophilia and Thrombosis Center, AOU Policlinico, Bari, Italy.
ORCID-Profile: Doris Barcellona, Alessandro Squizzato
Zitieren
APA
Galliazzo, S., Bucciarelli, P., Barcellona, D., Ciampa, A., Grandone, E., Malcangi, G., Rescigno, G., Squizzato, A., Toschi, V., Testa, S., & Poli, D. (2024). Practical Suggestions for an Optimal Management of Vitamin K Antagonists: Italian Federation of Centers for the Diagnosis of Thrombotic Disorders and the Surveillance of the Antithrombotic Therapies (FCSA) Position Paper. Thrombosis and Haemostasis, 124(08), 803-809. https://doi.org/10.1055/s-0044-1782688
Vancouver
Galliazzo S, Bucciarelli P, Barcellona D, Ciampa A, Grandone E, Malcangi G, et al. Practical Suggestions for an Optimal Management of Vitamin K Antagonists: Italian Federation of Centers for the Diagnosis of Thrombotic Disorders and the Surveillance of the Antithrombotic Therapies (FCSA) Position Paper. Thrombosis and Haemostasis. 2024;124(08):803-809. doi:10.1055/s-0044-1782688
BibTeX
@article{Galliazzo2024,
author = {Galliazzo, Silvia and Bucciarelli, Paolo and Barcellona, Doris and Ciampa, Antonio and Grandone, Elvira and Malcangi, Giuseppe and Rescigno, Giuseppe and Squizzato, Alessandro and Toschi, Vincenzo and Testa, Sophie and Poli, Daniela},
title = {Practical Suggestions for an Optimal Management of Vitamin K Antagonists: Italian Federation of Centers for the Diagnosis of Thrombotic Disorders and the Surveillance of the Antithrombotic Therapies (FCSA) Position Paper},
journal = {Thrombosis and Haemostasis},
year = {2024},
volume = {124},
number = {08},
pages = {803--809},
doi = {10.1055/s-0044-1782688}
}
EUVIMED